These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 27913128

  • 41. Outpatient Total Hip Arthroplasty in the United States: A Population-based Comparative Analysis of Complication Rates.
    Arshi A, Leong NL, Wang C, Buser Z, Wang JC, SooHoo NF.
    J Am Acad Orthop Surg; 2019 Jan 15; 27(2):61-67. PubMed ID: 30247308
    [Abstract] [Full Text] [Related]

  • 42. The Influence of Modifiable, Postoperative Patient Variables on the Length of Stay After Total Hip Arthroplasty.
    Farley KX, Anastasio AT, Premkumar A, Boden SD, Gottschalk MB, Bradbury TL.
    J Arthroplasty; 2019 May 15; 34(5):901-906. PubMed ID: 30691932
    [Abstract] [Full Text] [Related]

  • 43. Increasing Burden of Total Hip Arthroplasty Revisions in Patients Between 45 and 64 Years of Age.
    Rajaee SS, Campbell JC, Mirocha J, Paiement GD.
    J Bone Joint Surg Am; 2018 Mar 21; 100(6):449-458. PubMed ID: 29557860
    [Abstract] [Full Text] [Related]

  • 44. Lupus is associated with poorer outcomes after primary total hip arthroplasty.
    Singh JA, Cleveland JD.
    Lupus; 2019 Jun 21; 28(7):834-842. PubMed ID: 31117886
    [Abstract] [Full Text] [Related]

  • 45. Risk Factors and Costs Associated With Clostridium difficile Colitis in Patients With Prosthetic Joint Infection Undergoing Revision Total Hip Arthroplasty.
    Delanois RE, George NE, Etcheson JI, Gwam CU, Mistry JB, Mont MA.
    J Arthroplasty; 2018 May 21; 33(5):1534-1538. PubMed ID: 29273290
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Inpatient mortality after primary total hip arthroplasty: analysis from the National Inpatient Sample database.
    Illingworth KD, El Bitar YF, Banerjee D, Scaife SL, Saleh KJ.
    J Arthroplasty; 2015 Mar 21; 30(3):369-73. PubMed ID: 25529285
    [Abstract] [Full Text] [Related]

  • 48. THAs Performed Within 6 Months of Clostridioides difficile Infection Are Associated with Increased Risk of 90-Day Complications.
    Douglas SJ, Remily EA, Sax OC, Pervaiz SS, Polsky EB, Delanois RE.
    Clin Orthop Relat Res; 2021 Dec 01; 479(12):2704-2711. PubMed ID: 34033616
    [Abstract] [Full Text] [Related]

  • 49. Hospital Discharge within 2 Days Following Total Hip or Knee Arthroplasty Does Not Increase Major-Complication and Readmission Rates.
    Sutton JC, Antoniou J, Epure LM, Huk OL, Zukor DJ, Bergeron SG.
    J Bone Joint Surg Am; 2016 Sep 07; 98(17):1419-28. PubMed ID: 27605685
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Does sickle cell disease increase risk of adverse outcomes following total hip and knee arthroplasty? A nationwide database study.
    Perfetti DC, Boylan MR, Naziri Q, Khanuja HS, Urban WP.
    J Arthroplasty; 2015 Apr 07; 30(4):547-51. PubMed ID: 25496931
    [Abstract] [Full Text] [Related]

  • 52. Comparison of In-Hospital Mortality, Length of Stay, Postprocedural Complications, and Cost of Single-Vessel Versus Multivessel Percutaneous Coronary Intervention in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction (from Nationwide Inpatient Sample [2006 to 2012]).
    Panaich SS, Arora S, Patel N, Schreiber T, Patel NJ, Pandya B, Gupta V, Grines CL, Deshmukh A, Badheka AO.
    Am J Cardiol; 2016 Oct 01; 118(7):950-8. PubMed ID: 27522303
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Cost analysis of staged versus simultaneous bilateral total knee and hip arthroplasty using a propensity score matching.
    Hou JF, Hu C, Zhang Y, Tian LQ, Liu YZ, Zhang C, Li J.
    BMJ Open; 2021 Mar 02; 11(3):e041147. PubMed ID: 33653742
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Perioperative morbidity and mortality following bilateral total hip arthroplasty.
    Rasouli MR, Maltenfort MG, Ross D, Hozack WJ, Memtsoudis SG, Parvizi J.
    J Arthroplasty; 2014 Jan 02; 29(1):142-8. PubMed ID: 23664280
    [Abstract] [Full Text] [Related]

  • 58. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes.
    Browne JA, Adib F, Brown TE, Novicoff WM.
    J Arthroplasty; 2013 Sep 02; 28(8 Suppl):34-7. PubMed ID: 23896359
    [Abstract] [Full Text] [Related]

  • 59. Decline in allogeneic blood transfusion usage in total hip arthroplasty patients: National Inpatient Sample 2009 to 2013.
    Gwam CU, Mistry JB, Etcheson JI, George NE, Connors G, Thomas M, Adamu H, Patel NG, Delanois RE.
    Hip Int; 2018 Jul 02; 28(4):382-390. PubMed ID: 29218687
    [Abstract] [Full Text] [Related]

  • 60. What enhances the in-hospital mortality following total hip arthroplasty? A national inpatient sample-based study.
    Viswanathan VK, Aggarwal VA, Subramanian S, Mounasamy V, Sambandam S.
    Arch Orthop Trauma Surg; 2023 Oct 02; 143(10):6423-6430. PubMed ID: 36976373
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.